Pioneering solutions to overcome biology's most complex barriers and transform therapeutic possibilities.
80–90% of disease drivers remain unreachable.
Most CNS therapies never cross the blood–brain barrier.
Precision delivery remains a daunting challenge.
At NovaCode, we harness the unparalleled versatility of peptides—and beyond—to rewrite these limits. Powered by our unbiased discovery platform and precision nano-delivery system, we aim to transform what's possible in human medicine.
Learn More About UsDriving innovation with state-of-the-art platforms designed to unlock novel therapeutics and ensure targeted delivery.
An unbiased, ultra-versatile system that unlocks novel multi-cyclic peptides and small molecules, built upon 35+ years of continuous innovation.
Explore Platform DetailsStimuli-responsive, tumor-targeting nanocarriers engineered for controlled, on-demand therapeutic delivery with enhanced efficacy and minimized toxicity.
Discover Delivery TechnologyFrom pioneering OBOC peptide libraries in 1991 to cutting-edge peptide-drug conjugates today, our history is built on relentless innovation and impact.
Our unique strengths position us at the forefront of therapeutic innovation.
Innovative discovery and delivery systems.
35+ years of continuous scientific innovation.
Addressing unreachable disease drivers effectively.
Partnering to accelerate medical breakthroughs.
Our research is foundational to our innovations. Explore our publications to understand the depth of our scientific expertise.
Journal Name, Year
Journal Name, Year
Journal Name, Year
NovaCode welcomes partners across discovery, development, and delivery. Let's build the next breakthroughs—together. We are actively seeking collaborations to leverage our cutting-edge platforms.